|
Cellceutix Featured on Front Page of Boston Business Journal(0) Cellceutix Corporation (OTCBB: CTIX) (“the Company”), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat unmet medical conditions, is pleased to announce that it was featured Friday, January 20th on the front page of the Boston Business Journal print edition. Owned by American City Business Journals, the Boston Business Journal is available in both print and online versions and reaches hundreds of thousands of subscribers each month. Read More |
Contacts and informationHave an opinion or news that you want to share?
|
Social networks |
Most popular categories |